bisoprolol has been researched along with Ehlers-Danlos Syndrome in 1 studies
Bisoprolol: A cardioselective beta-1 adrenergic blocker. It is effective in the management of HYPERTENSION and ANGINA PECTORIS.
Ehlers-Danlos Syndrome: A heterogeneous group of autosomally inherited COLLAGEN DISEASES caused by defects in the synthesis or structure of FIBRILLAR COLLAGEN. There are numerous subtypes: classical, hypermobility, vascular, and others. Common clinical features include hyperextensible skin and joints, skin fragility and reduced wound healing capability.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gorosabel, MC | 1 |
| Dubacher, N | 1 |
| Meienberg, J | 1 |
| Matyas, G | 1 |
1 other study available for bisoprolol and Ehlers-Danlos Syndrome
| Article | Year |
|---|---|
Vascular Ehlers-Danlos syndrome: can the beneficial effect of celiprolol be extrapolated to bisoprolol?
Topics: Adrenergic beta-1 Receptor Antagonists; Animals; Aorta, Thoracic; Aortic Aneurysm, Thoracic; Aortic | 2020 |